-
Lipid Nanoparticle-Based Inhibitors for SARS-CoV-2 Host Cell Infection
28 Mar 2024 13:58 GMT
… emergence of a novel SARS-coronavirus-2 (SARS-CoV-2) and the … antiviral agents effective against SARS-CoV-2 focused on … . These results confirmed that SARS-CoV-2 pseudotyped lentivirus infected … efficiency (luciferase expression) of SARS-CoV-2 S pseudotyped …
-
Annual Two-Dose SARS-CoV-2 Vaccination Campaign Beneficial
27 Mar 2024 06:42 GMT
… a second dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine … effectiveness of an annual SARS-CoV-2 vaccination … States; the intervention included SARS-CoV-2 vaccination with … to protect individuals against SARS-CoV-2 infection and …
-
Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients
26 Mar 2024 03:34 GMT
… on the evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in immunocompromised … patients.
Persistent SARS-CoV-2 infection in individuals … has been ineffective at reducing coronavirus disease 2019 (COVID-19) …
-
Finding Inhibitors of a SARS-CoV-2 Helicase
24 Mar 2024 04:37 GMT
… , new antiviral agents to cure coronavirus-related infections are interesting research … identify possible inhibitors of the SARS-CoV-2 NSP13 helicase (pictured … a broad-spectrum drug for coronavirus infections. According to the team …
-
Experts to start drawing up recommendations for ‘long covid’
28 Mar 2024 13:39 GMT
… confirmed infection with the SARS-CoV-2 coronavirus, usually three months after … in the wake of severe acute respiratory syndrome due to coronavirus (SARS-CoV-2) and ‘long …
-
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
28 Mar 2024 12:00 GMT
… , the first potential dual coronavirus-norovirus oral antiviral
Initiation of … . COVID-19 and Other Coronavirus Programs
By targeting viral replication … by coronaviruses including COVID-19, Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory …
-
The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19
27 Mar 2024 22:01 GMT
Coronavirus disease 2019 (COVID-19) is a respiratory illness caused by severe acute respiratory syndrome coronavirus … 2 (SARS-CoV-2). The … were laboratory-confirmed SARS-CoV-2 positive by …
-
VIDEO: Measles comeback may be the first of many, says expert
27 Mar 2024 14:35 GMT
… administered in childhood. Unlike the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that evolved …
-
Shared Immune Associations Between COVID-19 and Inflammatory Bowel Disease: A Cross-Sectional Observational Study in Shanghai, China
27 Mar 2024 10:58 GMT
… respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has … Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 9 … novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and …
-
Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients
27 Mar 2024 11:00 GMT
… COVID-19 Bemnifosbuvir targets the SARS-CoV-2 RNA polymerase (nsp12 … both replication and transcription of SARS-CoV-2. Bemnifosbuvir has a … for serious viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus …